• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Poll

POLL: Are You Looking Forward to More Bio-similars on the Market?

Author(s):

Dermatology Times Staff

Click here to answer this weeks poll.

Yes
No
Related Videos
Related Content
A Paradox of Anti-Inflammatory Biologics
August 26th 2024

A Paradox of Anti-Inflammatory Biologics

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
September 23rd 2021

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

Mindera Health and Liviniti Partner to Improve the Management of Psoriasis With Precision Medicine
February 29th 2024

Mindera Health and Liviniti Partner to Improve the Management of Psoriasis With Precision Medicine

Biologic Therapies: Innovative Treatments Confront Real-World Challenges
February 8th 2024

Biologic Therapies: Innovative Treatments Confront Real-World Challenges

Abeona Files Briefing Package For EB-101 Pre-Biologics License Application
July 31st 2023

Abeona Files Briefing Package For EB-101 Pre-Biologics License Application

Cyltezo Added to Express Scripts' National Preferred Formulary
July 13th 2023

Cyltezo Added to Express Scripts' National Preferred Formulary

© 2024 MJH Life Sciences

All rights reserved.